Taigen Biopharmaceutica (Taiwan) Today
Taigen Biopharmaceutica is selling for under 10.80 as of the 31st of January 2025; that is 0.92 percent decrease since the beginning of the trading day. The stock's lowest day price was 10.8. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 31st of January 2025. Click here to learn more.
Valuation
Check how we calculate scores
Taigen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Taigen Biopharmaceutica's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Taigen Biopharmaceutica or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Taigen Biopharmaceuticals Holdings (4157) is traded on Taiwan OTC Exchange in Taiwan and employs 23 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 11.33 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Taigen Biopharmaceutica's market, we take the total number of its shares issued and multiply it by Taigen Biopharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Taigen Biopharmaceutica operates under Biotechnology sector and is part of Health Care industry. The entity has 716.84 M outstanding shares.
Taigen Biopharmaceutica generates positive cash flow from operations, but has no cash available
Check Taigen Biopharmaceutica Probability Of Bankruptcy
Taigen Biopharmaceutica Risk Profiles
Although Taigen Biopharmaceutica's alpha and beta are two of the key measurements used to evaluate Taigen Biopharmaceutica's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.3 | |||
| Standard Deviation | 2.07 | |||
| Variance | 4.29 | |||
| Risk Adjusted Performance | (0.15) |
Taigen Stock Against Markets
Taigen Biopharmaceutica Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Taigen Biopharmaceutica stock to make a market-neutral strategy. Peer analysis of Taigen Biopharmaceutica could also be used in its relative valuation, which is a method of valuing Taigen Biopharmaceutica by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Taigen Biopharmaceutica Corporate Management
Elected by the shareholders, the Taigen Biopharmaceutica's board of directors comprises two types of representatives: Taigen Biopharmaceutica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taigen. The board's role is to monitor Taigen Biopharmaceutica's management team and ensure that shareholders' interests are well served. Taigen Biopharmaceutica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taigen Biopharmaceutica's outside directors are responsible for providing unbiased perspectives on the board's policies.
| ChiHsin King | VP Research | Profile | |
| MingChu Hsu | Founder Director | Profile | |
| KuoLung Huang | CEO, Chairman | Profile | |
| Richard Lu | VP Fin | Profile |
Additional Tools for Taigen Stock Analysis
When running Taigen Biopharmaceutica's price analysis, check to measure Taigen Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taigen Biopharmaceutica is operating at the current time. Most of Taigen Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Taigen Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taigen Biopharmaceutica's price. Additionally, you may evaluate how the addition of Taigen Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.